Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
120 participants
INTERVENTIONAL
2016-09-14
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ICU Experience in Family Members
NCT02940028
ICU Family Communication Study
NCT00720200
Family Support Intervention in Intensive Care Units
NCT05280691
Benefits of the Involvement of Nurses in Meetings Between Physicians and the Families of Patients in the ICU.
NCT01745406
Impact of an ICU Diary on the Well-being of Patients and Families. A Prospective Multicenter Mixed Study
NCT02519725
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Families Excluded From Presence at Procedures
Families not invited to remain for ICU procedures
Placebo/Control
Family members will not be invited to remain in the ICU room
Families Invited to Be Present at Procedures
Families invited to remain for ICU procedures
Families Invited to Be Present at Procedures
Family members will be invited (but not required) to remain in the ICU room during procedures, if patients agree
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Families Invited to Be Present at Procedures
Family members will be invited (but not required) to remain in the ICU room during procedures, if patients agree
Placebo/Control
Family members will not be invited to remain in the ICU room
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to read \& speak English
* Family member of a patient or a patient that has undergone one of these procedures at any point during the ICU stay (if the procedure occurs from Sunday at 8 am to Friday at 12 pm): intubation, central line placement, arterial line placement, bronchoscopy, thoracentesis, chest tube placement, paracentesis and lumbar puncture
* Physician (both attending physicians and trainees) and nurses who work in the ICU during the study period.
Exclusion Criteria
* Non-English speaking individuals
* Children (\<18 years of age)
* Participants with dementia, psychiatric disorder with psychosis, schizophrenia or known cognitive dysfunction (established from chart review, report and/or score greater than or equal to 3 on IQ Code screening).
* Provider who does not want to participate
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Utah
OTHER
Intermountain Health Care, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sarah Beesley
Pulmonologist - Shock Trauma ICU
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah J Beesley, MD
Role: PRINCIPAL_INVESTIGATOR
Intermountain Health Care, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Intermountain Medical Center
Murray, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1050086
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.